SCV Biotech Reports Success in Arthritis Candidate Study

“We look forward to developing safe and effective alternative therapies for a range of inflammatory diseases such as Crohn's disease, ulcerative colitis, psoriasis, and for the inflammation that worsens diabetes and heart disease. This approach could …
See all stories on this topic »